Director Clinical Ophthalmology, Heidelberg - Novaliq GmbH - Pharma - jobvector

Diese Stellenanzeige ist abgelaufen. Finden Sie hier zahlreiche ähnliche Jobs.

Director Clinical Ophthalmology

 Novaliq GmbH  Heidelberg
Novaliq, based in Heidelberg, is a speciality, pharmaceutical company focused on ophthalmology. Our mission is to transform poorly soluble drugs into effective, ocular therapeutics for both the front and back of the eye. Novaliq’s proprietary EyeSol® technology enhances the topical bio-availability, stability and safety of traditionally insoluble or unstable drugs, improving the delivery, efficacy and convenience of treatments for ocular surface diseases, including dry eye, through preservative free and multi dose formulations. We have developed a family of tiered, truly differentiated and long-term sustainable dry eye products that addresses the different needs of dry eye patients. Our most advanced product is the CE-approved NovaTears®, marketed in Europe under the brand name EvoTears®. CyclASol® a second-generation prescription drug is currently in the pivotal phase of clinical development. More on

We are currently looking for a
Director Clinical Ophthalmology

Your main responsibilities
  • Integrating the scientific rationale, regulatory requirements, product development plans and commercial goals to build a strategic framework for the Clinical Development Plan
  • Playing a leadership role in managing clinical trials from phase I-IV across all geographic areas (mainly US, EU and Japan)
  • Scientific and medical planning, managing and supervising the conduct, evaluation and reporting of clinical studies and indication specific preclinical pharmacology studies
  • Developing and reviewing protocols and interacting with key external opinion leaders regarding protocol development
  • Supervising clinical monitoring, site and project management for national and international clinical studies of phases I-IV
  • Interacting with and representing us in communications with regulatory authorities and key opinion leaders in therapeutic indication
  • Primary contact for the CROs, ensuring that studies run within planned timelines and budget at sponsor site and according to required quality standards
  • Contributing the clinical section to respective documents (IND, IB, IMPD, publications, etc.)

Your profile
  • Science or Medical graduate (or equivalent) with a minimum of 8 years’ experience working in a healthcare industry
  • Five years of progressive responsibilities in drug development, and a proven track record for clinical and scientific leadership in drug development would be ideal
  • Profound industry experience (minimum 8 years working in interdisciplinary clinical project teams)
  • Knowledge of ICH-GCP and / or GLP and CRO management
  • Experience in Ophthalmology desired
  • Strategic mindset; thinks and acts globally
  • Proven track record of effective planning and organizational skills
  • Excellent communication skills in both German and English

What we offer
  • A highly innovative, international and challenging environment on the forefront of new treatments in ophthalmology
  • A well established and promising product pipeline in advanced clinical stages
  • An open, communicative atmosphere with numerous opportunities for personal growth and development – “fun” being a fundamental feature!
  • A competitive salary, flexible working hours and a wide range of social benefits
Kontakt für Bewerbungen
Set your eyes on the future – contact us!
Please send your written application in English (incl. CV, certificates, salary expectations and possible start date) via email to State the reference number DCO-0118.

Novaliq GmbH  •  Im Neuenheimer Feld 515   •  D-69120 Heidelberg   •
Bitte beziehen Sie sich bei Ihrer Bewerbung auf jobvector und geben Sie die folgende Referenznummer an: DCO-0118

Über Novaliq GmbH

About Novaliq – Novaliq GmbH, founded in 2007, is a Heidelberg based specialty pharmaceutical company focused on ophthalmology. Its mission is to transform poorly soluble drugs into effective ocular therapeutics for both the front and the back of the eye. Novaliq’s proprietary EyeSol® technology enhances the topical bio-availability, stability and safety of traditionally insoluble or unstable...

Mehr über die Novaliq GmbH

Täglich neue Jobs per E-Mail erhalten